BioHubNet Launches EQUIP: New Funding for Biomanufacturing Innovators
Biomanufacturing Hub Network (BioHubNet) Launches EQUIP Funding Program Featuring VentureConnect and VentureLift Grants
BioHubNet Receives $19 Million in Federal Funding to Address HQP Shortage in Biomanufacturing
- Leadership: Led by Molly Shoichet, Gilbert Walker, and Darius Rackus to drive biomanufacturing talent development.
- Federal Funding: Secured $18.9 million from CBRF and BRIF to tackle workforce shortages.
- National Role: Part of HI3, a $72 million initiative enhancing biomanufacturing capacity.
- Workforce Training: Developing 1,000 skilled workers through diverse training programs.
- Industry Collaboration: Partners with 26 organizations, including colleges and biotech firms.
- Diversity Focus: Committed to supporting underrepresented groups in life sciences.
Partner Updates
March 24, 26 & 28 | 2-5 PM
Apply by: March 17, 2025
Lab2Market Validate Foundations for Physicians is a 3-day virtual program offering a deep dive into research commercialization best practices.
March 26, 3– 5 PM
Paul Cadario Conference Centre
H2i’s 2025 FemSTEM Pitch Competition is almost here! Register now to attend and hear from six remarkable women-led teams tackling today’s pressing health challenges!
Apr. 2, 2025 – Join BioHubNet at “Unlocking Resources for Life Sciences Innovation”
BioHubNet is excited to connect with entrepreneurs to explore funding opportunities, commercialization strategies, and resources that drive life sciences innovation.
Partner Institutions
The Canadian Hub for Health Intelligence and Innovation in Infectious Diseases (HI3) plays a vital role in supporting BioHubNet by offering a collaborative network of nearly 100 partners and advanced resources in life sciences and engineering. As part of HI3, BioHubNet benefits from strategic alignment with Canada’s Biomanufacturing and Life Sciences Strategy, enabling talent development, commercialization, and national health preparedness. This integration strengthens BioHubNet’s efforts to address workforce shortages and accelerate biomanufacturing innovation.